| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.3 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.3 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |